Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
LA
Standard BioTools Inc. Common Stock
LAB
Mkt Cap
$248.5M
Volume
611.76K
Next Earnings
November 3rd
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
LA
LAB
LA
Standard BioTools Inc. Common Stock
LAB
News
·
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—IRDM, VRME, VAL and LAB
Mkt Cap
$258.5M
Volume
611.76K
Next Earnings
November 3rd
Chart
Financials
Earnings
News
About
Insider
Filings
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—IRDM, VRME, VAL and LAB
Monteverde & Associates PC is investigating four merger transactions to determine if shareholders are receiving fair value. The investigations cover Iridium Communications' sale to Rocket Lab, VerifyMe's merger with Open World Ltd, Valaris' sale to Transocean Ltd, and Standard Biotools' merger with Treeline Biosciences. The firm is offering free consultations to shareholders with concerns about these deals.
GlobeNewswire Inc. · Sep 9, 2026
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AstroNova, Inc. (Nasdaq – ALOT), Open Lending Corporation (Nasdaq – LPRO), Huntsman Corporation (NYSE – HUN), Standard BioTools Inc. (Nasdaq – LAB)
Brodsky & Smith law firm is investigating four merger transactions to determine whether company boards breached fiduciary duties to shareholders. The investigations concern AstroNova (being acquired by Arcline for $29.00/share), Open Lending (being acquired by ANV Group for $3.15/share), Huntsman (merging with Olin in a stock exchange), and Standard BioTools (being acquired by Treeline Biosciences). The firm is seeking shareholders to discuss whether fair processes were conducted and fair value provided.
GlobeNewswire Inc. · Jun 19, 2026
Standard BioTools and Treeline Biosciences Announce Merger Agreement
Standard BioTools (NASDAQ:LAB) and Treeline Biosciences announced a definitive merger agreement to combine in an all-stock transaction. The combined company will operate as Treeline Biosciences under ticker 'TRLN' and will be led by Treeline CEO Josh Bilenker. The merger is expected to close in the second half of 2026, with the combined entity having over $900 million in cash runway into 2029. Standard BioTools stockholders will own approximately 16% of the combined company, while Treeline stockholders will own approximately 84%. Standard BioTools will divest its Mass Cytometry and Microfluidics businesses to maximize shareholder value.
Benzinga · Jun 8, 2026
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026
Standard BioTools Inc. (NASDAQ: LAB) announced it will publish its first quarter 2026 financial results on Tuesday, May 5, 2026, after U.S. market close. The company is a leading provider of mass cytometry and microfluidics technologies for biomedical research.
GlobeNewswire Inc. · Apr 21, 2026
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Standard BioTools Inc. (NASDAQ: LAB) announced it will release its fourth quarter and full year 2025 financial results on February 24, 2026. The company also completed the sale of SomaLogic to Illumina for $350 million upfront with up to $425 million in total proceeds, leaving the company with approximately $550 million in cash and cash equivalents.
GlobeNewswire Inc. · Feb 10, 2026
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
Standard BioTools will report its second quarter 2025 financial results on August 11, 2025, hosting a conference call at 4:30 p.m. ET to discuss financial performance and operational progress.
GlobeNewswire Inc. · Jul 21, 2025
Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025
Standard BioTools Inc. (NASDAQ: LAB) announced that it will report its first quarter 2025 financial results on May 6, 2025, and host a conference call to discuss the results and operational progress.
GlobeNewswire Inc. · Apr 22, 2025
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
Standard BioTools Inc. (NASDAQ: LAB) announced preliminary and unaudited revenue results for the fourth quarter and full year 2024, with expected revenue of approximately $46.5 million for Q4 2024 and $174 million for the full year 2024. The company's CEO discussed progress in reducing operating expenses and plans to leverage the company's foundation to scale and shift revenues towards high-margin offerings.
GlobeNewswire Inc. · Jan 13, 2025
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Standard BioTools Inc. (NASDAQ: LAB) announced that its President and CEO, Michael Egholm, PhD, will present at the upcoming 43rd Annual J.P. Morgan Healthcare Conference on January 16th, 2024.
GlobeNewswire Inc. · Dec 19, 2024
Standard BioTools Appoints Alex Kim as Chief Financial Officer
Standard BioTools Inc. announced the appointment of Alex Kim as its new Chief Financial Officer, effective November 11, 2024. Kim, a co-founder and former Chief Operating Officer, brings extensive financial and operational experience in the healthcare and life sciences industries.
GlobeNewswire Inc. · Nov 7, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
LA
LAB
Standard BioTools Inc. Common Stock
Buy
Sell
Market
Limit
Soon
LAB
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any LAB yet.
Related Tickers
Earnings